Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236116 · ClinicalTrials.gov registry record · NA
Almond Consumption and Glycemia
A NA study of Glucose Intolerance and Glucose Metabolism Disorders (Including Diabetes Mellitus), sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 3
- Study locations
NCT03236116 is a NA study of Glucose Intolerance and Glucose Metabolism Disorders (Including Diabetes Mellitus) that has completed, run by Purdue University. The registered enrollment target is 75 participants, below the 3,854-participant average among 14 other Glucose Intolerance trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT03236116, a NA study of Glucose Intolerance and Glucose Metabolism Disorders (Including Diabetes Mellitus), has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will examine the effects of almonds consumed by adults with different body fat distributions on indices of carbohydrate and lipid metabolism.
Conditions Studied
Interventions
- OTHER Almonds
- OTHER Control (no nuts)
Study Locations (3)
Indiana
- Indiana University School of Medicine - Indianapolis
- Purdue University - West Lafayette
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236116
The ClinicalTrials.gov registry entry for NCT03236116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,854-participant average among 14 other Glucose Intolerance trials with a reported enrollment target (98% lower). The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Glucose Intolerance appearing as the primary indexed condition, and to 2 interventions - of which Almonds is the first listed.
NCT03236116 reports 3 study locations spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03236116 about?
NCT03236116 is a clinical study titled "Almond Consumption and Glycemia". This study will examine the effects of almonds consumed by adults with different body fat distributions on indices of carbohydrate and lipid metabolism.
What is the current status of trial NCT03236116?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2017-08-01. Estimated completion is 2020-12-31.
What conditions does trial NCT03236116 study?
This clinical trial studies the following conditions: Glucose Intolerance, Glucose Metabolism Disorders (Including Diabetes Mellitus), Lipid Metabolism Disorder, Appetite Disorders.
What interventions are being tested in trial NCT03236116?
The interventions under investigation include: Almonds (OTHER), Control (no nuts) (OTHER).
Who is sponsoring clinical trial NCT03236116?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03236116 being conducted?
This trial has 3 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glucose Intolerance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU
RECRUITING · NA
-
Time to Move in Pregnancy Hyperglycemia
RECRUITING · NA
-
The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults
RECRUITING · NA
-
Sleep and Metabolism
RECRUITING · NA
-
The Acute T-Rex (Timing of Resistance Exercise) Study
RECRUITING · NA
-
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Glucose Intolerance
All registered trials for this condition
Glucose Metabolism Disorders (Including Diabetes Mellitus)
All registered trials for this condition
Indiana
All trials with a study site in Indiana
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.